Cuvrior
Payments companies reported to CMS as associated with Cuvrior. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cuvrior, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cuvrior
These are the largest totals companies reported as associated with Cuvrior. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Regino Gonzalez-Peralta | Orlando, FL | Pediatric Gastroenterology | $10,817.82 |
| Amanda Cheung | Chicago, IL | Hepatology | $7,181.21 |
| Valentina Medici | Sacramento, CA | Gastroenterology (Internal Medicine) | $6,499.28 |
| Robert Gish | Folsom, CA | Hepatology | $6,185.90 |
| Lin Zhang | Sacramento, CA | Neurology (Psychiatry & Neurology) | $5,931.38 |
| Mitesh Lotia | Winter Park, FL | Neurology (Psychiatry & Neurology) | $5,740.43 |
| Michael Schilsky | New Haven, CT | Internal Medicine | $5,475.03 |
| Peter Hedera | Louisville, KY | Neurology (Psychiatry & Neurology) | $4,234.57 |
| Matthew Lorincz | Ann Arbor, MI | Neurology (Psychiatry & Neurology) | $3,719.58 |
| Danny Bega | Chicago, IL | Neurology (Psychiatry & Neurology) | $3,626.54 |
Prescribed Cuvrior?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.